Why did Orgo shares rally in the last trading session?
Oct 15, 2020 · ORGO went on to state that it expects to report a positive GAAP net income and adjusted EBITDA for both the fourth quarter and the fiscal full-year period. After-hours trading has seen the company’s stock price jump almost 39% higher to $5.25 per share after the previous days close at $3.78.
Can organogenesis (Orgo) run higher on rising earnings estimates?
Feb 16, 2022 · Published. Feb 16, 2022 8:54AM EST. O rganogenesis (ORGO) shares rallied 7.4% in the last trading session to close at $8.03. This move can be attributable to notable volume with a higher number of ...
Where can I buy shares of Orgo?
May 12, 2022 · Real-time trade and investing ideas on Organogenesis Holdings Inc - Ordinary Shares - Class A ORGO from the largest community of traders and investors.
Why did organogenesis get delisted from the NASDAQ?
Apr 17, 2022 · Organogenesis' stock was trading at $2.98 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, ORGO stock has increased by 108.4% and is now trading at $6.21. View which stocks have been most impacted by COVID-19.
Will Orgo stock go up?
The 4 analysts offering 12-month price forecasts for Organogenesis Holdings Inc have a median target of 19.50, with a high estimate of 25.00 and a low estimate of 13.00. The median estimate represents a +253.26% increase from the last price of 5.52.
Is Orgo stock a good buy?
When did Phun go public?
Is PHUN a good stock?
Did PHUN stock split?
What are warrants on stock?
Is Organogenesis a buy right now?
3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Organogenesis in the last twelve months. There are currently 3 bu...
How has Organogenesis' stock been impacted by Coronavirus?
Organogenesis' stock was trading at $2.98 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (...
Are investors shorting Organogenesis?
Organogenesis saw a increase in short interest in February. As of February 15th, there was short interest totaling 10,300,000 shares, an increase o...
When is Organogenesis' next earnings date?
Organogenesis is scheduled to release its next quarterly earnings announcement on Monday, May 9th 2022. View our earnings forecast for Organogenes...
How were Organogenesis' earnings last quarter?
Organogenesis Holdings Inc. (NASDAQ:ORGO) posted its quarterly earnings data on Tuesday, March, 1st. The company reported $0.41 EPS for the quarter...
What guidance has Organogenesis issued on next quarter's earnings?
Organogenesis issued an update on its FY 2022 earnings guidance on Tuesday, March, 15th. The company provided earnings per share guidance of for th...
What price target have analysts set for ORGO?
3 analysts have issued twelve-month target prices for Organogenesis' shares. Their forecasts range from $20.00 to $25.00. On average, they expect O...
Who are Organogenesis' key executives?
Organogenesis' management team includes the following people: Gary S. Gillheeney , President, Chief Executive Officer & Director ( LinkedIn Prof...
Who are some of Organogenesis' key competitors?
Some companies that are related to Organogenesis include Zai Lab (ZLAB) , CureVac (CVAC) , Karuna Therapeutics (KRTX) , HUTCHMED (HCM) , Arvin...
3.5 Analyst's Opinion
Is Organogenesis a buy right now?
Organogenesis has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.
How has Organogenesis' stock price been impacted by COVID-19?
3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Organogenesis in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Organogenesis stock. View analyst ratings for Organogenesis or view top-rated stocks.
When is Organogenesis' next earnings date?
Organogenesis' stock was trading at $2.98 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ORGO shares have increased by 117.1% and is now trading at $6.47. View which stocks have been most impacted by COVID-19.
How can I listen to Organogenesis' earnings call?
Organogenesis is scheduled to release its next quarterly earnings announcement on Tuesday, March 1st 2022. View our earnings forecast for Organogenesis.
How were Organogenesis' earnings last quarter?
Organogenesis will be holding an earnings conference call on Tuesday, March 1st at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 404-537-3406 with passcode "5998131".
What guidance has Organogenesis issued on next quarter's earnings?
Organogenesis Holdings Inc. (NASDAQ:ORGO) released its quarterly earnings data on Tuesday, November, 9th. The company reported $0.09 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.06 by $0.03.
Does Maxx Chatsko have a position in any of the stocks mentioned?
Organogenesis updated its FY 2021 earnings guidance on Tuesday, December, 7th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $458 million-$470 million, compared to the consensus revenue estimate of $462.50 million.
What is organogenesis bandage?
Maxx Chatsko has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.